Zobrazeno 1 - 10
of 123
pro vyhledávání: '"Taro Ikeda"'
Publikováno v:
SAGE Open Medicine, Vol 11 (2023)
Objectives: To identify useful biomarkers by reviewing laboratory data for a predictor of the clinical course following treatment with radium-223 dichloride (Ra-223) in patients with metastatic castration-resistant prostate cancer. Methods: Eighteen
Externí odkaz:
https://doaj.org/article/4e66c96fd9664fbb938f8d01c8dee677
Publikováno v:
IJU Case Reports, Vol 5, Iss 1, Pp 15-18 (2022)
Introduction Immune checkpoint inhibitors are one of the standard treatments for metastatic renal cell carcinoma. Among immune‐related adverse events, the sarcoidosis‐like reaction is frequently difficult to differentiate from cancer progression.
Externí odkaz:
https://doaj.org/article/2ae471a07043465a9bf03adcd32b37f1
Autor:
Taro Ikeda, Masaaki Mitsutsuji, Takuya Okada, Isamu Yamada, Ryunosuke Konaka, Yukari Adachi, Akiko Matsumoto, Takahiro Wada, Naoki Harada, Masahiro Samizo
Publikováno v:
Surgical Case Reports, Vol 7, Iss 1, Pp 1-7 (2021)
Abstract Background Non-traumatic mesenteric hematomas are usually well controlled, with no resulting symptoms. Herein, we report a case in which collapse of a large mesenteric hematoma, after rupture of a right colic artery aneurysm, caused small bo
Externí odkaz:
https://doaj.org/article/f7e15bdfb0f34b54bb47163551f1fa3f
Publikováno v:
Case Reports in Urology, Vol 2022 (2022)
A 70-year-old male was diagnosed with urothelial carcinoma of the upper renal pelvis on the left side of the horseshoe kidney. Preoperative thin-slice contrast-enhanced CT with three-dimensional reconstruction of the images revealed that two arteries
Externí odkaz:
https://doaj.org/article/482693b592934e5ba929f9c67c4acdc3
Publikováno v:
Case Reports in Urology, Vol 2021 (2021)
We report a patient with advanced bladder cancer in which the primary lesion and metastatic site disappeared following the pembrolizumab therapy rechallenge after radiotherapy for bladder cancer lesion of nonresponse of pembrolizumab first challenge.
Externí odkaz:
https://doaj.org/article/15ca940fd45c403db695c7382e0662c6
Autor:
Taro Ikeda, Shingo Kanaji, Gosuke Takiguchi, Naoki Urakawa, Hiroshi Hasegawa, Masashi Yamamoto, Yoshiko Matsuda, Kimihiro Yamashita, Takeru Matsuda, Taro Oshikiri, Tetsu Nakamura, Satoshi Suzuki, Yoshihiro Kakeji
Publikováno v:
SAGE Open Medicine, Vol 8 (2020)
Objectives: Dissection of the No. 11p lymph nodes is technically challenging because of variations in anatomical landmarks. This study aimed to determine the accuracy and efficacy of predicting the dorsal landmark of No. 11p lymph node using three-di
Externí odkaz:
https://doaj.org/article/e1f0a2242dfb44dfb250c54c499cd9c4
Autor:
Liangcheng Wang, Emi Shimizu, Taro Ikeda, Aya Ishiguro, Yuko Irie, Hiroyoshi Ko, Isao Horiuchi, Kenro Chikazawa, Ken Imai, Tomoyuki Kuwata, Kenjiro Takagi
Publikováno v:
Clinical Case Reports, Vol 8, Iss 4, Pp 774-775 (2020)
Abstract Most fetal ovarian cysts increase in size during the late stages of pregnancy. Early treatment of a huge neonatal cyst may reduce the risk of gastrointestinal obstruction.
Externí odkaz:
https://doaj.org/article/b9862856a144406c80ffe4f229cb17e5
Publikováno v:
Transactions of the Society of Instrument and Control Engineers. 58:159-167
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a7dac4d68f4c962999bca6e57ec0141c
https://doi.org/10.9746/sicetr.58.159
https://doi.org/10.9746/sicetr.58.159
Publikováno v:
IEEE Control Systems Letters. 6:397-402
This paper aims to improve the reliability of optimal control using models constructed by machine learning methods. Optimal control problems based on such models are generally non-convex and difficult to solve online. In this paper, we propose a mode
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec436fa6bcb923b3e53b13517066fbfd
https://doi.org/10.1109/lcsys.2021.3077201
https://doi.org/10.1109/lcsys.2021.3077201
Publikováno v:
IJU Case Reports, Vol 5, Iss 1, Pp 15-18 (2022)
IJU Case Reports
IJU Case Reports
Introduction Immune checkpoint inhibitors are one of the standard treatments for metastatic renal cell carcinoma. Among immune‐related adverse events, the sarcoidosis‐like reaction is frequently difficult to differentiate from cancer progression.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43c1db41e7b497885d39b6610796b14c
https://doaj.org/article/2ae471a07043465a9bf03adcd32b37f1
https://doaj.org/article/2ae471a07043465a9bf03adcd32b37f1